Assi H - Search Results

1

Prone versus Supine FDG PET/CT in the Staging of Breast Cancer.

Nassar L, Kassas M, Abi-Ghanem AS, El-Jebai M, Al-Zakleet S, Baassiri AS, Naccoul RA, Barakat A, Tfayli A, Assi H, Berjawi G, Estrada-Lobato E, Giammarile F, Vinjamuri S, Haidar M. Nassar L, et al. Among authors: assi h. Diagnostics (Basel). 2023 Jan 19;13(3):367. doi: 10.3390/diagnostics13030367. Diagnostics (Basel). 2023. PMID: 36766472 Free PMC article.

2

Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib.

Melosky B, Agulnik J, Assi H. Melosky B, et al. Among authors: assi h. Curr Oncol. 2008 Dec;15(6):279-85. doi: 10.3747/co.v15i6.382. Curr Oncol. 2008. PMID: 19079629 Free PMC article.

3

Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial.

Assi H, Missenard G, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, Meric JB, Tursz T, Lecesne A. Assi H, et al. Curr Oncol. 2010 Nov;17(6):23-31. doi: 10.3747/co.v17i6.578. Curr Oncol. 2010. PMID: 21151406 Free PMC article.

4

Immune toxicities and long remission duration after ipilimumab therapy for metastatic melanoma: two illustrative cases.

Assi H, Wilson KS. Assi H, et al. Curr Oncol. 2013 Apr;20(2):e165-9. doi: 10.3747/co.20.1265. Curr Oncol. 2013. PMID: 23559884 Free PMC article.

5

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer.

Andre F, Cabioglu N, Assi H, Sabourin JC, Delaloge S, Sahin A, Broglio K, Spano JP, Combadiere C, Bucana C, Soria JC, Cristofanilli M. Andre F, et al. Among authors: assi h. Ann Oncol. 2006 Jun;17(6):945-51. doi: 10.1093/annonc/mdl053. Epub 2006 Apr 20. Ann Oncol. 2006. PMID: 16627550 Free article.

6

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.

Weber J, Thompson JA, Hamid O, Minor D, Amin A, Ron I, Ridolfi R, Assi H, Maraveyas A, Berman D, Siegel J, O'Day SJ. Weber J, et al. Among authors: assi h. Clin Cancer Res. 2009 Sep 1;15(17):5591-8. doi: 10.1158/1078-0432.CCR-09-1024. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671877 Clinical Trial.

7

[Expression of chemokine receptors by cancer cells].

André F, Soria JC, Assi H, Delaloge S, Spielmann M. André F, et al. Among authors: assi h. Bull Cancer. 2004 Dec 1;91 Suppl 4:S254-6. Bull Cancer. 2004. PMID: 15899617 Review. French.

8

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer.

Andre F, Khalil A, Slimane K, Massard C, Mathieu MC, Vignot S, Assi H, Delaloge S, Spielmann M. Andre F, et al. Among authors: assi h. J Clin Oncol. 2005 May 1;23(13):2996-3000. doi: 10.1200/JCO.2005.08.046. J Clin Oncol. 2005. PMID: 15860855 Clinical Trial.

9

Severe gastrointestinal hemorrhage during targeted therapy for advanced breast carcinoma.

Assi H, Abdel-Samad N. Assi H, et al. Curr Oncol. 2014 Oct;21(5):e732-5. doi: 10.3747/co.21.2038. Curr Oncol. 2014. PMID: 25302045 Free PMC article.

10

Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.

Thompson JA, Hamid O, Minor D, Amin A, Ron IG, Ridolfi R, Assi H, Berman D, Siegel J, Weber JS. Thompson JA, et al. Among authors: assi h. J Immunother. 2012 Jan;35(1):73-7. doi: 10.1097/CJI.0b013e31823735d6. J Immunother. 2012. PMID: 22130164 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page